RUO‘ZENLog in
Stocks › Healthcare › WGS

GeneDx stockWGS

GeneDx Holdings Corp · Nasdaq
$64.36
−7.18% on the day
close Nov 5, 2026
What is happening with the stock

GeneDx trades at $64.36, 62.3% below its 52-week high (Dec 2, 2025). The price is below its 50- and 200-day averages, a downtrend. −50.5% year to date, −53.0% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 9, 2026.

Closing price, 6 monthsdetailed chart in the terminal
38.0772.0410652-week high 170.87 — above the chartMay 8, 2026Nov 5, 2026
Reported figurestrailing 12 months
🔒 Sector comparison, estimates and ratings are in the terminal

Ratings, candles, signals and the screener for WGS — after you log in

Open the terminal
From 52-week high−62.3%
High170.87 Dec 2, 2025
vs 50-day avg−16.8%
vs 200-day avg−9.6%
Year to date−50.5%
12 months−53.0%
Dividend yieldnone
EarningsNov 9
Market cap$1.9B
Chart patterncup with handle
Exchange · sinceNasdaq

Frequently asked questions about GeneDx

What is the GeneDx stock price?

At the close on Nov 5, 2026: $64.36 (−7.18% on the day). 52-week high: $170.87 on Dec 2, 2025. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.

When does GeneDx report earnings?

The next quarterly report is on Nov 9, 2026. Last quarter, earnings per share changed −98% year over year, revenue +11%.

Does GeneDx pay dividends?

No, GeneDx does not pay dividends.

Where does GeneDx trade and how to buy it?

Ticker WGS, exchange Nasdaq. You can buy it through a broker with access to US exchanges.

Should I buy GeneDx now?

We do not give buy or sell advice. Ratings, the detailed chart and signals for WGS are in the terminal after you log in.

Similar stocks

More on WGS

Included in lists